A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis.

Gold, Deborah T; Martin, Bradley C; Frytak, Jennifer R; Amonkar, Mayur M; Cosman, Felicia

Gold, Deborah T; Martin, Bradley C; Frytak, Jennifer R; Amonkar, Mayur M; Cosman, Felicia.

Affiliation

Gold DT; Duke University Medical Center, Durham, NC 27710, USA. dtg@geri.duke.edu

Curr Med Res Opin ; 23(3): 585-94, 2007 Mar.

Article in En | MEDLINE | ID: mdl-17355739

Subject(s)

Alendronate/administration & dosage; Bone Density Conservation Agents/administration & dosage; Fractures, Spontaneous/epidemiology; Osteoporosis, Postmenopausal/drug therapy; Age Distribution; Aged; Bone Density/drug effects; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Fractures, Spontaneous/prevention & control; Humans; Incidence; Middle Aged; Osteoporosis, Postmenopausal/diagnosis; Patient Compliance; Probability; Proportional Hazards Models; Registries; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis, Postmenopausal / Alendronate / Bone Density Conservation Agents / Fractures, Spontaneous Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Curr Med Res Opin Year: 2007 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links